Based on our data, considering that both p-p38 and p-ERK1/2 are two key components of the MAPK pathway, we conclude that EMP2 suppressed tumor cell growth mainly by inhibition of MAPK pathway in NSCLC. This evidence concerns the gene EMP2 and non-small cell lung carcinoma.